Atrial Fibrillation Trial, Recruiting NCT06500988 Sponsor: Johns Hopkins University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06500988
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older at the time of signing consent
  • People who have been diagnosed with atrial fibrillation (an irregular heart rhythm) that either comes and goes in episodes lasting less than 7 days, or has been ongoing for 7 days or longer
  • People with a Body Mass Index (BMI) of 27.0 or above (a measure of body weight relative to height)

Who may not be able to join:

  • People whose atrial fibrillation has been classified as permanent, meaning a decision has already been made not to try to restore a normal heart rhythm
  • People with severe disease affecting the heart valves
  • People with moderate narrowing of the mitral valve (a valve in the heart)
  • People who have previously had heart surgery
  • People who have an implanted heart device (such as a pacemaker or defibrillator)
  • People who have had a cardiac arrest (when the heart has stopped beating) at any point in the past
  • People whose heart pumping function is significantly reduced, specifically a left ventricular ejection fraction of 35% or below (confirm with trial site)
  • People whose life expectancy is less than one year
  • People who do not speak English
  • People whose treating doctor considers exercise to be unsafe for them
  • People who are considered unsuitable for the study for any other reason, as determined by the principal investigator

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nino Isakadze, MD, Johns Hopkins University

Phone: 410-955-5999

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 June 2025
Est. completion
1 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Participants Freedom from documented atrial tachyarrhythmia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov